Javelin Mortgage Investment Corp (JMI) Announces Monthly Dividend of $0.23

Javelin Mortgage Investment Corp (NYSE:JMI) announced a monthly dividend on Thursday, June 13th, AnalystRatings.Net reports. Stockholders of record on Thursday, August 15th will be paid a dividend of $0.23 per share on Thursday, August 29th. This represents a $2.76 annualized dividend and a dividend yield of 17.59%. The ex-dividend date is Tuesday, August 13th.

JMI has been the subject of a number of recent research reports. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Javelin Mortgage Investment Corp in a research note to investors on Tuesday. They now have a $17.00 price target on the stock, down previously from $19.00. On the ratings front, analysts at Ladenburg Thalmann initiated coverage on shares of Javelin Mortgage Investment Corp in a research note to investors on Monday. They set a “buy” rating and a $21.00 price target on the stock. Finally, analysts at Credit Suisse initiated coverage on shares of Javelin Mortgage Investment Corp in a research note to investors on Wednesday, June 5th. They set a “neutral” rating on the stock.

Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $20.22.

Shares of Javelin Mortgage Investment Corp (NYSE: JMI) opened at 15.69 on Friday. Javelin Mortgage Investment Corp has a 52 week low of $14.53 and a 52 week high of $20.20. The stock’s 50-day moving average is currently $17.69. The company has a market cap of $117.7 million and a P/E ratio of 4.18.

JAVELIN Mortgage Investment Corp. is formed to invest in and manage a leveraged portfolio of agency mortgage-backed securities, non-agency mortgage-backed securities and other mortgage-related investments.

Latest News

Analyzing United Overseas Bank  and Wells Fargo
Analyzing United Overseas Bank and Wells Fargo
Financial Comparison: COLOPLAST A/S/ADR  vs. Its Competitors
Financial Comparison: COLOPLAST A/S/ADR vs. Its Competitors
Financial Survey: Interpace Diagnostics Group  versus Apollo Endosurgery
Financial Survey: Interpace Diagnostics Group versus Apollo Endosurgery
UnitedHealth Group  Price Target Increased to $300.00 by Analysts at BMO Capital Markets
UnitedHealth Group Price Target Increased to $300.00 by Analysts at BMO Capital Markets
VICI Properties  Lifted to “Buy” at Zacks Investment Research
VICI Properties Lifted to “Buy” at Zacks Investment Research
TJX Companies  Stock Rating Upgraded by ValuEngine
TJX Companies Stock Rating Upgraded by ValuEngine


© 2006-2018 Ticker Report. Google+.